Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

Leo should use Remde plus standard of care in both moderate and severe cv19 patients for the controlled group.

For critically ill patients, it will be Bril plus standard of care vs standard of care alone.

Mild is a gimme.

Big Pharma will be salivating once the lung in-vivo assay comes out. That's GOING TO BE GREAT AND THAT I CAN GUARANTEE TO YOU ALL! Imagine Bril working in and saving people's lives in severely and critically ill patients with ARDS?! Wow!!

My gold standard? Leaving no stone unturned even if IPIX was listed on OTC. Bril has up to $10b clinical application potential, imo. I'm in at 7, 9,... Thank you!

GB